Early Effects of Denosumab in Postmenopausal Women with Low Bone Mineral Density Previously Treated with Alendronate

被引：0
|
作者：
Brown, J. P. [1 ]
Kendler, D. L. [2 ]
Benhamou, C. L. [3 ]
Lillestol, M. [4 ]
Roux, C. [5 ]
Siddhanti, S. [6 ]
Man, H. S. [6 ]
Martin, J. San [6 ]
Bone, H. G. [7 ]
机构：
[1] Univ Laval, CHUQ, Quebec City, PQ, Canada
[2] Clin Res Ctr, Vancouver, BC, Canada
[3] Ctr Hosp, Orleans, France
[4] Internal Med Associates, Fargo, ND USA
[5] Hop Cochin, F-75674 Paris, France
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
[7] Michigan Bone & Mineral Clin, Detroit, MI USA
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3973 / 3974
页数：2
相关论文
共 50 条
  • [1] DENOSUMAB COMPARED WITH ALENDRONATE IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN PREVIOUSLY TREATED WITH ALENDRONATE
    Bernad, M.
    Garces, M.
    Martin Mola, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 768 - 768
  • [2] Effects of Denosumab vs Alendronate on Bone Mineral Density (BMD), Bone Turnover Markers (BTM), and Safety in Women Previously Treated with Alendronate.
    Kendler, D. L.
    Benhamou, C. L.
    Brown, J. P.
    Lillestol, M.
    Roux, C.
    Man, H. S.
    Siddhanti, S.
    Martin, J. San
    Bone, H. G.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S473 - S473
  • [3] Denosumab in postmenopausal women with low bone mineral density
    McClung, MR
    Lewiecki, EM
    Cohen, SB
    Bolognese, MA
    Woodson, GC
    Moffett, AH
    Peacock, M
    Miller, PD
    Lederman, SN
    Chesnut, CH
    Lain, D
    Kivitz, AJ
    Holloway, DL
    Zhang, C
    Peterson, MC
    Bekker, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08): : 821 - 831
  • [4] Alendronate and estrogen effects in postmenopausal women with low bone mineral density
    Bone, HG
    Greenspan, SL
    McKeever, C
    Bell, N
    Davidson, M
    Downs, RW
    Emkey, R
    Meunier, PJ
    Miller, SS
    Mulloy, AL
    Recker, RR
    Weiss, SR
    Heyden, N
    Musliner, T
    Suryawanshi, S
    Yates, AJ
    Lombardi, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02): : 720 - 726
  • [5] Denosumab in postmenopausal women with low bone mineral density
    Schwartzman, Julie
    Yazici, Yusuf
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (22): : 2390 - 2390
  • [6] Denosumab in postmenopausal women with low bone mineral density
    Charles L. Loprinzi
    [J]. Current Oncology Reports, 2006, 8 (4) : 267 - 268
  • [7] DENOSUMAB FOLLOWING LONG-TERM ALENDRONATE IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY
    Kendler, David L.
    Roux, Christian
    Benhamou, Claude-Laurent
    Brown, Jacques P.
    Lillestol, Mike
    Siddhanti, Suresh
    Man, Hoi-Shen
    San Martin, Javier
    Bone, Henry G.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S215 - S215
  • [8] Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women Transitioning From Alendronate Therapy
    Kendler, David L.
    Roux, Christian
    Benhamou, Claude Laurent
    Brown, Jacques P.
    Lillestol, Michael
    Siddhanti, Suresh
    Man, Hoi-Shen
    Martin, Javier San
    Bone, Henry G.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (01) : 72 - 81
  • [9] Effects of denosumab on bone mineral density and bone turnover in postmenopausal women
    Bone, Henry G.
    Bolognese, Michael A.
    Yuen, Chui Kin
    Kendler, David L.
    Wang, Huei
    Liu, Yu
    Martin, Javier San
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (06): : 2149 - 2157
  • [10] Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women
    Wensel, Terri M.
    Iranikhah, Maryam M.
    Wilborn, Teresa W.
    [J]. PHARMACOTHERAPY, 2011, 31 (05): : 510 - 523
12345